|
1
|
Penfold SA, Coughlan MT, Patel SK,
Srivastava PM, Sourris KC, Steer D, Webster DE, Thomas MC, MacIsaac
RJ, Jerums G, et al: Circulating high-molecular-weight RAGE ligands
activate pathways implicated in the development of diabetic
nephropathy. Kidney Int. 78:287–295. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fujiu K, Manabe I and Nagai R: Renal
collecting duct epithelial cells regulate inflammation in
tubulointerstitial damage in mice. J Clin Invest. 121:3425–3441.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhou J, Wu R, High AA, Slaughter CA,
Finkelstein D, Rehg JE, Redecke V and Häcker H: A20-binding
inhibitor of NF-κB (ABIN1) controls Toll-like receptor-mediated
CCAAT/enhancer-binding protein β activation and protects from
inflammatory disease. Proc Natl Acad Sci USA. 108:E998–E1006. 2011.
View Article : Google Scholar
|
|
4
|
Gu W, Cui J, Shi M, Zhang R, Tan D, Zhang
X and Zhang H: Serum myeloid-related protein 8/14 is a potential
predictor of diabetic kidney disease. Discov Med. 30:97–105.
2020.
|
|
5
|
Dessing MC, Tammaro A, Pulskens WP, Teske
GJ, Butter LM, Claessen N, van Eijk M, van der Poll T, Vogl T, Roth
J, et al: The calcium-binding protein complex S100A8/A9 has a
crucial role in controlling macrophage-mediated renal repair
following ischemia/reperfusion. Kidney Int. 87:85–94. 2015.
View Article : Google Scholar
|
|
6
|
Chen Q, Sun P, Zhou J, Long T, Xiao A, Liu
Z, Xu S, Lei W, Zhang R, Tian J, et al: Renal tubular GSDME
protects cisplatin nephrotoxicity by impeding OGT-STAT3-S100A7A
axis in male mice. Nat Commun. 16:68072025. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nazari A, Khorramdelazad H, Hassanshahi G,
Day AS, Sardoo AM, Fard ET, Abedinzadeh M and Nadimi AE: S100A12 in
renal and cardiovascular diseases. Life Sci. 191:253–258. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Curran CS and Kopp JB: RAGE pathway
activation and function in chronic kidney disease and COVID-19.
Front Med (Lausanne). 9:9704232022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ometto F, Friso L, Astorri D, Botsios C,
Raffeiner B, Punzi L and Doria A: Calprotectin in rheumatic
diseases. Exp Biol Med (Maywood). 242:859–873. 2017. View Article : Google Scholar :
|
|
10
|
Pepper RJ, Wang HH, Rajakaruna GK,
Papakrivopoulou E, Vogl T, Pusey CD, Cook HT and Salama AD:
S100A8/A9 (calprotectin) is critical for development of
glomerulonephritis and promotes inflammatory leukocyte-renal cell
interactions. Am J Pathol. 185:1264–1274. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Du L, Chen Y, Shi J, Yu X, Zhou J, Wang X,
Xu L, Liu J, Gao J, Gu X, et al: Inhibition of S100A8/A9
ameliorates renal interstitial fibrosis in diabetic nephropathy.
Metabolism. 144:1553762023. View Article : Google Scholar
|
|
12
|
Chuang CT, Guh JY, Lu CY, Chen HC and
Chuang LY: S100B is required for high glucose-induced pro-fibrotic
gene expression and hypertrophy in mesangial cells. Int J Mol Med.
35:546–552. 2015. View Article : Google Scholar
|
|
13
|
Takahashi N, Yokoi S, Kimura H, Naiki H,
Matsusaka T, Yamamoto Y, Nakatani K, Kasuno K and Iwano M:
Renoprotective effects of extracellular fibroblast specific protein
1 via nuclear factor erythroid 2-related factor-mediated
antioxidant activity. Sci Rep. 13:225402023. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun Y, Fan Y, Wang Z, Li M, Su D, Liu Y
and Liang X: S100A16 promotes acute kidney injury by activating
HRD1-induced ubiquitination and degradation of GSK3β and CK1α. Cell
Mol Life Sci. 79:1842022. View Article : Google Scholar
|
|
15
|
Yang X, Zheng F, Yan P, Liu X, Chen X, Du
X, Zhang Y, Wang P, Chen C, Lu H and Bai Y: S100A2 activation
promotes interstitial fibrosis in kidneys by FoxO1-mediated
epithelial-mesenchymal transition. Cell Biol Toxicol. 40:862024.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Amaya-Garrido A, Brunet M, Buffin-Meyer B,
Piedrafita A, Grzesiak L, Agbegbo E, Del Bello A, Ferrandiz I,
Ardeleanu S, Bermudez-Lopez M, et al: Calprotectin is a contributor
to and potential therapeutic target for vascular calcification in
chronic kidney disease. Sci Transl Med. 15:eabn59392023. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Komatsuda A, Ohtani H, Wakui H, Chyzh KA,
Hatakeyama T, Iwamoto K, Maki N, Kimura T, Hitomi J and Sawada K:
Increased serum levels of S100A12 in patients with
MPO-ANCA-associated glomerulonephritis. Clin Nephrol. 66:315–321.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hara M, Ando M, Morito T, Nokiba H, Iwasa
Y, Tsuchiya K and Nitta K: S100A12 gene expression is increased in
peripheral leukocytes in chronic kidney disease stage 4-5 patients
with cardiovascular disease. Nephron Clin Pract. 123:202–208. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gawdzik J, Mathew L, Kim G, Puri TS and
Hofmann Bowman MA: Vascular remodeling and arterial calcification
are directly mediated by S100A12 (EN-RAGE) in chronic kidney
disease. Am J Nephrol. 33:250–259. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Okada H, Ban S, Nagao S, Takahashi H,
Suzuki H and Neilson EG: Progressive renal fibrosis in murine
polycystic kidney disease: An immunohistochemical observation.
Kidney Int. 58:587–597. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nishitani Y, Iwano M, Yamaguchi Y, Harada
K, Nakatani K, Akai Y, Nishino T, Shiiki H, Kanauchi M, Saito Y and
Neilson EG: Fibroblast-specific protein 1 is a specific prognostic
marker for renal survival in patients with IgAN. Kidney Int.
68:1078–1085. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Muñoz-Félix JM, López-Novoa JM and
Martínez-Salgado C: Heterozygous disruption of activin
receptor-like kinase 1 is associated with increased renal fibrosis
in a mouse model of obstructive nephropathy. Kidney Int.
85:319–332. 2014. View Article : Google Scholar
|
|
23
|
Liang M, Wang Y, Liang A, Mitch WE,
Roy-Chaudhury P, Han G and Cheng J: Migration of smooth muscle
cells from the arterial anastomosis of arteriovenous fistulas
requires Notch activation to form neointima. Kidney Int.
88:490–502. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li Y, Kang YS, Dai C, Kiss LP, Wen X and
Liu Y: Epithelial-to-mesenchymal transition is a potential pathway
leading to podocyte dysfunction and proteinuria. Am J Pathol.
172:299–308. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kie JH, Kapturczak MH, Traylor A, Agarwal
A and Hill-Kapturczak N: Heme oxygenase-1 deficiency promotes
epithelial-mesenchymal transition and renal fibrosis. J Am Soc
Nephrol. 19:1681–1691. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang Y, Liang A, Luo J, Liang M, Han G,
Mitch WE and Cheng J: Blocking Notch in endothelial cells prevents
arteriovenous fistula failure despite CKD. J Am Soc Nephrol.
25:773–783. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Humphreys BD, Lin SL, Kobayashi A, Hudson
TE, Nowlin BT, Bonventre JV, Valerius MT, McMahon AP and Duffield
JS: Fate tracing reveals the pericyte and not epithelial origin of
myofibroblasts in kidney fibrosis. Am J Pathol. 176:85–97. 2010.
View Article : Google Scholar
|
|
28
|
Prunotto M, Chaykovska L, Bongiovanni M,
Frattini M, Cagarelli T, Weibel F, Bruschi M, de Herreros AG and
Moll S: Tubular cytoplasmic expression of zinc finger protein SNAI1
in renal transplant biopsies: A sign of diseased epithelial
phenotype? Am J Pathol. 187:55–69. 2017. View Article : Google Scholar
|
|
29
|
Wang Y, Zhou J, Minto AW, Hack BK,
Alexander JJ, Haas M, Li YC, Heilig CW and Quigg RJ: Altered
vitamin D metabolism in type II diabetic mouse glomeruli may
provide protection from diabetic nephropathy. Kidney Int.
70:882–891. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cheng CW, Rifai A, Ka SM, Shui HA, Lin YF,
Lee WH and Chen A: Calcium-binding proteins annexin A2 and S100A6
are sensors of tubular injury and recovery in acute renal failure.
Kidney Int. 68:2694–2703. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jung DH, Kim YS and Kim JS: KIOM-79
prevents S100b-induced TGF-beta1 and fibronectin expression in
mouse mesangial cells. J Ethnopharmacol. 125:374–379. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Park BS, Lee HW, Lee YJ, Park S, Kim YW,
Kim SE, Kim IH, Park JH and Park KM: Serum S100B represents a
biomarker for cognitive impairment in patients with end-stage renal
disease. Clin Neurol Neurosurg. 195:1059022020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Elmer J, Jeong K, Abebe KZ, Guyette FX,
Murugan R, Callaway CW and Rittenberger JC; Pittsburgh Post-Cardiac
Arrest Service: Serum Neutrophil Gelatinase-associated lipocalin
predicts survival after resuscitation from cardiac arrest. Crit
Care Med. 44:111–1119. 2016. View Article : Google Scholar
|
|
34
|
Heller F, Frischmann S, Grünbaum M, Zidek
W and Westhoff TH: Urinary calprotectin and the distinction between
prerenal and intrinsic acute kidney injury. Clin J Am Soc Nephrol.
6:2347–2355. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Seibert FS, Pagonas N, Arndt R, Heller F,
Dragun D, Persson P, Schmidt-Ott K, Zidek W and Westhoff TH:
Calprotectin and neutrophil gelatinase-associated lipocalin in the
differentiation of pre-renal and intrinsic acute kidney injury.
Acta Physiol (Oxf). 207:700–708. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Waldecker-Gall S, Waldecker CB, Babel N,
Baraliakos X, Seibert F and Westhoff TH: Urinary calprotectin as a
diagnostic tool for detecting significant bacteriuria. Sci Rep.
14:122302024. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dwivedi RC, Navarrete M, Choi N, Spicer V,
Rigatto C, Arora RC, Krokhin O, Ho J and Wilkins JA: A proteomic
evaluation of urinary changes associated with cardiopulmonary
bypass. Clin Proteomics. 13:172016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen JJ, Fan PC, Kou G, Chang SW, Chen YT,
Lee CC and Chang CH: Meta-analysis: Urinary calprotectin for
discrimination of intrinsic and prerenal acute kidney injury. J
Clin Med. 8:742019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
John JS, Deepthi RV, Rebekah G, Prabhu SB,
Ajitkumar P, Mathew G and Agarwal I: Usefulness of urinary
calprotectin as a novel marker differentiating functional from
structural acute kidney injury in the critical care setting. J
Nephrol. 36:695–704. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Seibert FS, Rosenberger C, Mathia S, Arndt
R, Arns W, Andrea H, Pagonas N, Bauer F, Zidek W and Westhoff TH:
Urinary calprotectin differentiates between prerenal and intrinsic
acute renal allograft failure. Transplantation. 101:387–394. 2017.
View Article : Google Scholar
|
|
41
|
Westhoff JH, Fichtner A, Waldherr S,
Pagonas N, Seibert FS, Babel N, Tönshoff B, Bauer F and Westhoff
TH: Urinary biomarkers for the differentiation of prerenal and
intrinsic pediatric acute kidney injury. Pediatr Nephrol.
31:2353–2363. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Rivetti G, Gizzone P, Petrone D, Di Sessa
A, Miraglia Del Giudice E, Guarino S and Marzuillo P: Acute kidney
injury in children: A focus for the general pediatrician. Children
(Basel). 11:10042024.PubMed/NCBI
|
|
43
|
Westhoff JH, Seibert FS, Waldherr S, Bauer
F, Tönshoff B, Fichtner A and Westhoff TH: Urinary calprotectin,
kidney injury molecule-1, and neutrophil gelatinase-associated
lipocalin for the prediction of adverse outcome in pediatric acute
kidney injury. Eur J Pediatr. 176:745–755. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nikolakopoulou Z, Hector LR, Creagh-Brown
BC, Evans TW, Quinlan GJ and Burke-Gaffney A: Plasma S100A8/A9
heterodimer is an early prognostic marker of acute kidney injury
associated with cardiac surgery. Biomark Med. 13:205–218. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang Z, Xu J, Zhang Y, Chen C, Kong C,
Tang L, Jiang Y, Yu R, Zong Q, Zhang L and Wang D: Prediction of
acute kidney injury incidence following acute type A aortic
dissection surgery with novel biomarkers: A prospective
observational study. BMC Med. 21:5032023. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Cai X, Li X, Shi J, Tang L, Yang J, Yu R,
Wang Z and Wang D: S100A8/A9 high-expression macrophages mediate
renal tubular epithelial cell damage in acute kidney injury
following acute type A aortic dissection surgery. Front Mol Biosci.
12:15307412025. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Shi W, Wan TT, Li HH and Guo SB: Blockage
of S100A8/A9 ameliorates septic nephropathy in mice. Front
Pharmacol. 14:11723562023. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Koçak G, Bilik G, Yeşilova A, Oyman F, Can
M and Cihan Ş: The evaluation of urinary calprotectin levels for
prediction of acute cisplatin-induced nephrotoxicity. Medicine
(Baltimore). 101:e298142022. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Racovitan D, Hogeweg M, Doevelaar AA,
Seidel M, Rohn B, Bettag S, Rieckmann S, Babel N, Seibert FS and
Westhoff TH: Urinary biomarkers to predict acute kidney damage and
mortality in COVID-19. Clin Nephrol. 99:161–171. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Bourgonje AR, Bourgonje MF, la Bastide-van
Gemert S, Nilsen T, Hidden C, Gansevoort RT, Mulder DJ, Hillebrands
JL, Bakker SJL, Dullaart RPF, et al: A prospective study of the
association between plasma calprotectin levels and New-Onset CKD in
the general population. Kidney Int Rep. 9:1265–1275. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Lee SY, Han K, Kwon HS, Koh ES and Chung
S: Fecal calprotectin as a prognostic biomarker for mortality and
renal outcomes in chronic kidney disease. Biomolecules. 15:5572025.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Samaey A, Vázquez-Castellanos JF,
Caenepeel C, Evenepoel P, Vermeire S, Raes J and Knops N: Effects
of fecal microbiota transplantation for recurrent Clostridium
difficile infection in children on kidney replacement therapy: A
pilot study. Pediatr Nephrol. 39:1201–1212. 2024. View Article : Google Scholar
|
|
53
|
Aquilani R, Bolasco P, Murtas S, Maestri
R, Iadarola P, Testa C, Deiana ML, Esposito MP, Contu R, Cadeddu M,
et al: Effects of a metabolic mixture on gut inflammation and
permeability in elderly patients with chronic kidney disease: A
Proof-of-concept study. Metabolites. 12:9872022. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Pepper RJ, Hamour S, Chavele KM, Todd SK,
Rasmussen N, Flint S, Lyons PA, Smith KG, Pusey CD, Cook HT and
Salama AD: Leukocyte and serum S100A8/S100A9 expression reflects
disease activity in ANCA-associated vasculitis and
glomerulonephritis. Kidney Int. 83:1150–1158. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Anton-Pampols P, Martínez Valenzuela L,
Fernández Lorente L, Quero Ramos M, Gómez Preciado F, Martín Capón
I, Morandeira F, Manrique Escola J, Fulladosa X, Cruzado JM, et al:
Combining neutrophil and macrophage biomarkers to detect active
disease in ANCA vasculitis: A combinatory model of calprotectin and
urine CD163. Clin Kidney J. 16:693–700. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Tantivitayakul P, Benjachat T, Somparn P,
Leelahavanichkul A, Kittikovit V, Hirankarn N, Pisitkun T and
Avihingsanon Y: Elevated expressions of myeloid-related proteins-8
and -14 are danger biomarkers for lupus nephritis. Lupus. 25:38–45.
2016. View Article : Google Scholar
|
|
57
|
Turnier JL, Fall N, Thornton S, Witte D,
Bennett MR, Appenzeller S, Klein-Gitelman MS, Grom AA and Brunner
HI: Urine S100 proteins as potential biomarkers of lupus nephritis
activity. Arthritis Res Ther. 19:2422017. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Kawasaki Y, Suyama K, Go H, Imamura T,
Ushijima Y, Sakai N, Hashimoto K and Hosoya M: Accumulation of
macrophages expressing myeloid-related protein 8 associated with
the progression of sclerotic changes in children with IgA
nephropathy. Tohoku J Exp Med. 218:49–55. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Amaya-Garrido A and Klein J: The role of
calprotectin in vascular calcification. Curr Opin Nephrol
Hypertens. 34:276–283. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Drueke TB and Massy ZA: Calprotectin, a
misnomer for another player in vascular calcification. Kidney Int.
105:915–918. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Schmaderer C, Kemmner S, Burkhardt K,
Heemann U and Baumann M: Serum myeloid-related protein 8/14 complex
is associated with microalbuminuria in patients with type 2
diabetes. Ther Adv Cardiovasc Dis. 8:80–88. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Tsai YC, Dai CY, Tsai MJ, Hwang SJ, Yu PS,
Hung WW, Pan SF, Wu LY, Tsai PH, Tsai HP, et al: Immune cell
infiltration and kynurenine pathway activation define early injury
and progression in diabetic nephropathy. Int J Biol Sci.
22:1389–1406. 2026. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Wang Y, Zhou X, Jiang Y, Jiang L, Gao L,
Liu X, Wang X, Sun C and Wu Y: Diagnostic immune-related markers
for diabetic kidney disease: A bioinformatics and machine learning
approach. Ren Fail. 47:25254672025. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Fedulovs A, Tzivian L, Zalizko P, Ivanova
S, Bumane R, Janeviča J, Krūzmane L, Krustins E and Sokolovska J:
Progression of diabetic kidney disease and gastrointestinal
symptoms in patients with type I diabetes. Biomedicines.
11:26792023. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Celikbilek A, Akyol L, Sabah S, Tanik N,
Adam M, Celikbilek M, Korkmaz M and Yilmaz N: S100B as a glial cell
marker in diabetic peripheral neuropathy. Neurosci Lett. 558:53–57.
2014. View Article : Google Scholar
|
|
66
|
Kim JK, Kim SG, Kim HJ and Song YR: Serum
S100B protein is associated with depressive symptoms in patients
with end-stage renal disease. Clin Biochem. 45:1573–1577. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Al-Hakeim HK, Twaij BAA-R, Al-Naqeeb TH,
Moustafa SR and Maes M: Neuronal damage and inflammatory biomarkers
are associated with the affective and chronic fatigue-like symptoms
due to end-stage renal disease. J Affect Disord. 347:220–229. 2024.
View Article : Google Scholar
|
|
68
|
Rabczyński M, Chwałek S, Adamiec-Mroczek
J, Lewandowski Ł, Trocha M, Nowak B, Misiuk-Hojło M,
Bednarska-Chabowska D, Kuźnik E, Lubieniecki P, et al: Neutrophil
Elastase, Neuron-Specific Enolase, and S100B protein as potential
markers of Long-term complications caused by COVID-19 in patients
with type 2 diabetes mellitus (T2DM) and advanced stage of diabetic
nephropathy (NfT2DM)-Observational studies. Int J Mol Sci.
25:117912024. View Article : Google Scholar
|
|
69
|
Sulaj A, Kopf S, Gröne E, Gröne HJ,
Hoffmann S, Schleicher E, Häring HU, Schwenger V, Herzig S, Fleming
T, et al: ALCAM a novel biomarker in patients with type 2 diabetes
mellitus complicated with diabetic nephropathy. J Diabetes
Complications. 31:1058–1065. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Luo Z, Zhang L, Wang Z, Xiong Q, Tang J,
Yang Y, Hu X, Ge H, Xiao X, Tang R and Lin W: Serum ALCAM is a
potential novel non-invasive marker for predicting the progression
of IgA nephropathy. BMC Nephrol. 26:7042025. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Lin L, Shi C, Sun Z, Le NT, Abe JI and Hu
K: The Ser/Thr kinase p90RSK promotes kidney fibrosis by modulating
fibroblast-epithelial crosstalk. J Biol Chem. 294:9901–9910. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Yang B, Vohra PK, Janardhanan R, Misra KD
and Misra S: Expression of profibrotic genes in a murine remnant
kidney model. J Vasc Interv Radiol. 22:1765–1772.e1. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Higgins DF, Kimura K, Bernhardt WM,
Shrimanker N, Akai Y, Hohenstein B, Saito Y, Johnson RS, Kretzler
M, Cohen CD, et al: Hypoxia promotes fibrogenesis in vivo via HIF-1
stimulation of epithelial-to-mesenchymal transition. J Clin Invest.
117:3810–3820. 2007.PubMed/NCBI
|
|
74
|
Harada K, Akai Y, Yamaguchi Y, Kimura K,
Nishitani Y, Nakatani K, Iwano M and Saito Y: Prediction of
corticosteroid responsiveness based on fibroblast-specific protein
1 (FSP1) in patients with IgA nephropathy. Nephrol Dial Transplant.
23:3152–3159. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Shiotsu Y, Mori Y, Hatta T, Maki N, Iida
K, Matsuoka E, Kado H, Ishida R, Kishimoto N, Tamagaki K, et al:
Plasma S100A12 levels and peripheral arterial disease in end-stage
renal disease. Nephron Extra. 1:242–250. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Isoyama N, Machowska A, Qureshi AR,
Yamamoto T, Anderstam B, Heimburger O, Barany P, Stenvinkel P and
Lindholm B: Elevated Circulating S100A12 associates with vascular
disease and worse clinical outcome in peritoneal dialysis patients.
Perit Dial Int. 36:269–276. 2016. View Article : Google Scholar
|
|
77
|
Isoyama N, Leurs P, Qureshi AR, Bruchfeld
A, Anderstam B, Heimburger O, Bárány P, Stenvinkel P and Lindholm
B: Plasma S100A12 and soluble receptor of advanced glycation end
product levels and mortality in chronic kidney disease Stage 5
patients. Nephrol Dial Transplant. 30:84–91. 2015. View Article : Google Scholar
|
|
78
|
Shiotsu Y, Mori Y, Nishimura M, Hatta T,
Imada N, Maki N, Iida K, Iwamoto N, Matsuoka E, Tamagaki K and
Kosaki A: Prognostic utility of plasma S100A12 levels to establish
a novel scoring system for predicting mortality in maintenance
hemodialysis patients: A two-year prospective observational study
in Japan. BMC Nephrol. 14:162013. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Schott C, Dilliott AA, Wang J, McIntyre
AD, Son S, Colaiacovo S, Baker C, Gunaratnam L, House AA, Susan
Huang SH, et al: Vascular calcification in chronic kidney disease
associated with pathogenic variants in ABCC6. Gene. 927:1487312024.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Lindholm B: Serum S100A12: A risk marker
or risk factor of vascular calcification in chronic kidney disease.
Am J Nephrol. 42:1–3. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Yan L, Mathew L, Chellan B, Gardner B,
Earley J, Puri TS and Hofmann Bowman MA: S100/Calgranulin-mediated
inflammation accelerates left ventricular hypertrophy and aortic
valve sclerosis in chronic kidney disease in a receptor for
advanced glycation end products-dependent manner. Arterioscler
Thromb Vasc Biol. 34:1399–1411. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Szeto CC, Kwan BC, Lai KB, Lai FM, Chow
KM, Wang G, Luk CC and Li PK: Urinary expression of kidney injury
markers in renal transplant recipients. Clin J Am Soc Nephrol.
5:2329–2337. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Borges NA, Barros AF, Nakao LS, Dolenga
CJ, Fouque D and Mafra D: Protein-bound uremic toxins from gut
microbiota and inflammatory markers in chronic kidney disease. J
Ren Nutr. 26:396–400. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Nilsen T, Sunde K and Larsson A: A new
turbidimetric immunoassay for serum calprotectin for fully
automatized clinical analysers. J Inflamm (Lond). 12:452015.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Tydén H, Lood C, Gullstrand B, Jönsen A,
Ivars F, Leanderson T and Bengtsson AA: Pro-inflammatory S100
proteins are associated with glomerulonephritis and anti-dsDNA
antibodies in systemic lupus erythematosus. Lupus. 26:139–149.
2017. View Article : Google Scholar
|
|
86
|
Mylemans M, Nevejan L, Van Den Bremt S,
Stubbe M, Cruyssen BV, Moulakakis C, Berthold H, Konrad C, Bossuyt
X and Van Hoovels L: Circulating calprotectin as biomarker in
neutrophil-related inflammation: Pre-analytical recommendations and
reference values according to sample type. Clin Chim Acta.
517:149–155. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Yu C, Dong Y, Zhong F, Zeng J and Fang Z:
Discovery and serological validation of DAMP-derived B-cell
epitopes as diagnostic biomarkers for diabetic nephropathy. Front
Endocrinol (Lausanne). 16:16529222025. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Yao W, Chen Y, Li Z, Ji J, You A, Jin S,
Ma Y, Zhao Y, Wang J, Qu L, et al: Single Cell RNA Sequencing
identifies a unique inflammatory macrophage subset as a druggable
target for alleviating acute kidney injury. Adv Sci (Weinh).
9:e21036752022. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Bai Y, Chi K, Zhao D, Shen W, Liu R, Hao
J, Cai G, Chen X and Hong Q: Identification of functional
heterogeneity of immune cells and tubular-immune cellular interplay
action in diabetic kidney disease. J Transl Int Med. 12:395–405.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Wen J, Jiao B, Tran M and Wang Y:
Pharmacological Inhibition of S100A4 Attenuates Fibroblast
Activation and Renal Fibrosis. Cells. 11:27622022. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Tammaro A, Florquin S, Brok M, Claessen N,
Butter LM, Teske GJD, de Boer OJ, Vogl T, Leemans JC and Dessing
MC: S100A8/A9 promotes parenchymal damage and renal fibrosis in
obstructive nephropathy. Clin Exp Immunol. 193:361–375. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Yamaguchi Y, Iwano M, Suzuki D, Nakatani
K, Kimura K, Harada K, Kubo A, Akai Y, Toyoda M, Kanauchi M, et al:
Epithelial-mesenchymal transition as a potential explanation for
podocyte depletion in diabetic nephropathy. Am J Kidney Dis.
54:653–664. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Yadav A, Vallabu S, Kumar D, Ding G,
Charney DN, Chander PN and Singhal PC: HIVAN phenotype: Consequence
of epithelial mesenchymal transdifferentiation. Am J Physiol Renal
Physiol. 298:F734–F744. 2010. View Article : Google Scholar
|
|
94
|
Jin R, Zhao A, Han S, Zhang D, Sun H, Li
M, Su D and Liang X: The interaction of S100A16 and GRP78 actives
endoplasmic reticulum stress-mediated through the IRE1α/XBP1
pathway in renal tubulointerstitial fibrosis. Cell Death Dis.
12:9422021. View Article : Google Scholar
|
|
95
|
Fresquet M, Jowitt TA, McKenzie EA, Ball
MD, Randles MJ, Lennon R and Brenchley PE: PLA2R binds to the
annexin A2-S100A10 complex in human podocytes. Sci Rep. 7:68762017.
View Article : Google Scholar
|
|
96
|
Belmokhtar K, Ortillon J, Jaisson S, Massy
ZA, Boulagnon Rombi C, Doué M, Maurice P, Fritz G, Gillery P,
Schmidt AM, et al: Receptor for advanced glycation end products: A
key molecule in the genesis of chronic kidney disease vascular
calcification and a potential modulator of sodium phosphate
co-transporter PIT-1 expression. Nephrol Dial Transplant.
34:2018–2030. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Panda DK, Bai X, Sabbagh Y, Zhang Y, Zaun
HC, Karellis A, Koromilas AE, Lipman ML and Karaplis AC: Defective
interplay between mTORC1 activity and endoplasmic reticulum
stress-unfolded protein response in uremic vascular calcification.
Am J Physiol Renal Physiol. 314:F1046–F1061. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Wen W, Sun J, Ma Y, Shi S, Zhang W, Li J
and Guo H: Renal protective effect of boeravinone B against
diabetic nephropathy rats via inhibition of the inflammatory and
JAK2/STAT3 signalling pathway. Cell J. 26:351–360. 2024.PubMed/NCBI
|
|
99
|
Chen Z, Ye L, Zhu M, Lin X, Wu J, Zhang X,
Wang Y, Hong X, Li Z, Hu S, et al: Multi-omics analysis identifies
S100a10/Anxa2 complex within proximal tubule aggravates acute
kidney injury through p-Stat3/Spp1 signaling. Transl Res.
284:57–68. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Draibe J, Pepper RJ and Salama AD:
Treatment with Quinoline-3-carboxamide does not successfully
prevent immune-mediated glomerulonephritis in mice. Nefrologia.
36:687–693. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Alaee M, Akbari A, Karami H, Salemi Z,
Amri J and Panahi M: Antidiabetic and protective effects of
Scrophularia striata ethanolic extract on diabetic nephropathy via
suppression of RAGE and S100A8 expression in kidney tissues of
streptozotocin-induced diabetic rats. J Basic Clin Physiol
Pharmacol. 31:201901862020. View Article : Google Scholar
|
|
102
|
Hsiao HW, Tsai KL, Wang LF, Chen YH,
Chiang PC, Chuang SM and Hsu C: The decline of autophagy
contributes to proximal tubular dysfunction during sepsis. Shock.
37:289–96. 2012. View Article : Google Scholar
|
|
103
|
Luque A, Serrano I, Ripoll E, Malta C,
Gomà M, Blom AM, Grinyó JM, Rodríguez de Córdoba S, Torras J and
Aran JM: Noncanonical immunomodulatory activity of complement
regulator C4BP(β-) limits the development of lupus nephritis.
Kidney Int. 97:551–566. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Singh N, Kesharwani A, Gajbhiye RL, Sankar
Sreenikethanam Hari H, Bharathavikru RS, Ravichandiran V and
Parihar VK: Hydroalcoholic extract of Benincasa hispida (Thunb.)
Cogn. reinstates renal structural and functional dynamics
compromised in diabetic mice: Molecular insights through
integration of transcriptomics and proteomics. J Ethnopharmacol.
362:1211322026. View Article : Google Scholar : PubMed/NCBI
|
